DC HEALTHCARE HOLDINGS BERHAD

KLSE (MYR): DCHCARE (0283)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.165

Today's Change

0.00 (0.00%)

Day's Change

0.165 - 0.165

Trading Volume

176,200

Financial
Market Cap

Market Cap

164 Million

NOSH

996 Million

Latest Quarter

Latest Quarter

30-Jun-2024 [#2]

Announcement Date

27-Aug-2024

Next Quarter

30-Sep-2024

Est. Ann. Date

30-Nov-2024

Est. Ann. Due Date

29-Nov-2024

QoQ | YoY

15.15% | -267.06%

T4Q Result

Revenue | NP to SH

56,421.000 | -18,434.000

RPS | P/RPS

5.66 Cent | 2.91

EPS | P/E | EY

-1.85 Cent | -8.92 | -11.21%

DPS | DY | Payout %

0.00 Cent | 0.00% | 0.00%

NAPS | P/NAPS

0.05 | 3.30

QoQ | YoY

-139.22% | -389.21%

NP Margin | ROE

-32.67% | -37.00%

F.Y. | Ann. Date

30-Jun-2024 | 27-Aug-2024

Latest Audited Result

Latest Audited Result

31-Dec-2023

Announcement Date

30-Apr-2024

Next Audited Result

31-Dec-2024

Est. Ann. Date

30-Apr-2025

Est. Ann. Due Date

29-Jun-2025

Annual (Unaudited)

Revenue | NP to SH

67,789.000 | 2,560.000

RPS | P/RPS

6.80 Cent | 2.43

EPS | P/E | EY

0.26 Cent | 64.21 | 1.56%

DPS | DY | Payout %

0.00 Cent | 0.00% | 0.00%

NAPS | P/NAPS

0.06 | 2.75

YoY

null%

NP Margin | ROE

3.78% | 4.28%

F.Y. | Ann. Date

31-Dec-2023 | 27-Feb-2024

Annualized Result

Revenue | NP to SH

46,670.000 | -29,240.000

RPS | P/RPS

4.68 Cent | 3.52

EPS | P/E | EY

-2.94 Cent | -5.62 | -17.79%

DPS | DY | Payout %

-

NAPS | P/NAPS

-

QoQ | YoY

7.57% | -329.37%

NP Margin | ROE

-62.65% | -58.70%

F.Y. | Ann. Date

30-Jun-2024 | 27-Aug-2024

Business Process

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 1 / 4 25.00% 1 / 8 12.50%
Total Positive Profit Years 0 / 4 0.00% 2 / 8 25.00%
Continuous Quarters Of Positive Profit 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Profit Growth 1 / 4 25.00% 1 / 8 12.50%
Continuous Quarters Of Adjusted EPS Growth 1 / 4 25.00% 1 / 8 12.50%
Total Dividend Years 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE -8.11% -0.10%
Average Net Profit Margin -38.95% -14.92%

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Quarters Of Revenue Growth 1 / 2 50.00% 1 / 2 50.00%
Total Positive Profit Years 1 / 2 50.00% 1 / 2 50.00%
Continuous Quarters Of Positive Profit 1 / 2 50.00% 1 / 2 50.00%
Continuous Quarters Of Profit Growth 1 / 2 50.00% 1 / 2 50.00%
Continuous Quarters Of Adjusted EPS Growth 1 / 2 50.00% 1 / 2 50.00%
Total Dividend Years 0 / 2 0.00% 0 / 2 0.00%
Continuous Quarters Of Dividend 0 / 2 0.00% 0 / 2 0.00%
Continuous Quarters Of Dividend Growth 0 / 2 0.00% 0 / 2 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 2 0.00% 0 / 2 0.00%
Average ROE 2.14% 2.14%
Average Net Profit Margin 1.89% 1.89%
Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 56,421 46,670 67,789 33,894 33,894
NP to SH -18,434 -29,240 2,560 1,280 1,280
Dividend 0 0 0 0 0
Adjusted EPS -1.85 -2.94 0.26 0.13 0.13
Adjusted DPS 0.00 0.00 0.00 0.00 0.00

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.

Growth

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 46.83% -22.42% -32.76% -1.59% 21.86%
NP to Owner 15.15% -267.06% -329.37% -45.62% -345.17%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00%
Adjusted EPS 15.19% -266.17% -329.77% -44.86% -342.89%
Adjusted DPS 0.00% 0.00% 0.00% 0.00% 0.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue -16.77% 66.46% 66.46% -31.15% 37.69% 37.69% 0.00% 100.00% 100.00%
NP to Owner -820.08% -1,540.16% -1,540.16% -1,242.19% -2,384.38% -2,384.38% 0.00% 100.00% 100.00%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Adjusted EPS -811.54% -1,523.08% -1,523.08% -1,230.77% -2,361.54% -2,361.54% 0.00% 100.00% 100.00%
Adjusted DPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Discussions
Be the first to like this. Showing 50 of 898 comments

Trianon

Have show at the end of this year because DC Healthcare will expand its business to Sabah and Sarawak by the end of this year

2 months ago

mudaBubu

market not that good recently, buy CHCARE on weakness first

2 months ago

Abram66

Wow, DC Healthcare has been acknowledged in Malaysia Book of Records for being the first aesthetic clinic chain listed on Bursa Malaysia's ACE Market

https://www.nst.com.my/business/corporate/2024/09/1104776/dc-healthcare-recognised-being-ace-markets-first-aesthetic-clinic

2 months ago

Hatiharihari

Place some buying orders at 16 cents for averaging 🙂

2 months ago

Bryson

all clear at 165, once new shop will start operating at q3 & can start to see some profit this quarter

2 months ago

Vdhawan

The company will ensure that aesthetic healthcare is not just a service, but a necessity for enhancing wellbeing. Vry nice ~

2 months ago

stockjobBB

20 sen coming?

2 months ago

Trianon

Yupe, buying volume is slowly increasing and it will break through 20 cents eventually

2 months ago

Abram66

Now this company has become very famous among Malaysians because of the advertisements they have done

1 month ago

mudaBubu

Q3 result good then confirm can fly higher than 20 sen

1 month ago

gkungpat

Need back to IPO price to gain trust..

1 month ago

Jimmy7890

Surface advertising only. Internal a lot of problems. Even their interviews are low standard, main problem many patients went to other aesthetic clinic, and complain Dr Chong quality, rather burn their left over package than going back. This is so bad

1 month ago

Jimmy7890

Seem like a lot of DCH own fans here lol

1 month ago

Bryson

Myfm sponsorship is pretty good - looking forward for q3 result

1 month ago

Jimmy7890

Yes. Saw all these naive comments without facts or research. Cannot tahan joined and gave my view. That’s called keyboard warrior FetcoveXX?

1 month ago

Jimmy7890

You are so smart to believe Google and FB reviews?

1 month ago

Jettson8

Jimmy7890 is from another aesthetic clinic which is not recognized by the Malaysia Book of Records ? 🤔 Why so jealous of DC healthcare getting interviewed?

1 month ago

Hatiharihari

This jimmy is talking nonsense without facts or research. Ignore him

1 month ago

stockjobBB

hahaha sour comment spotted! DCHCARE doubling down on penang healthcare hub/tourism, see you above 0.20 soon

1 month ago

gkungpat

How can investors believe that after just one year the price fell cheaper than the IPO price?
Dr Chong pun cong jugak ke?
🤔🤔🤔

1 month ago

Abram66

The company may use the funds saved from cancelling the RM70 million acquisition of I Bella Sdn Bhd for share buybacks 😁

1 month ago

marcelle5

Dr chong will push the share price up lah, ez tp 0.20

1 month ago

Birdie

10 cents coming......

1 month ago

TrInvestor

wah dream too much, I want pick up at 10 sen too

1 month ago

Fuzzywuzzy

Sales should improve at end of year.... almost new year soon

1 month ago

Trianon

It will show us a huge improvement in third quarter performance. Rest assured

1 month ago

Vdhawan

In the mean time, collect before it breaks 20 sen again

1 month ago

gkungpat

Current Price below IPO price maaa..
What happen Dr Chong..??

1 month ago

Travisbravis

big announcement soon, dr chong wont let us down

1 month ago

gkungpat

@Travisbravis
big announcement soon, dr chong wont let us down

@marcelle5
Dr chong will push the share price up lah, ez tp 0.20

.........................................................................................................

Just after 1 year the market share price felt below IPO price..
also the technical chart stick all negative shown STRONG SELLLLLLLLLL...
All in just 1 yearrrrrrr...

huhuhuhu

1 month ago

Hatiharihari

Traders are often short-sighted. Look at Gen Z nowadays, the aesthetic industry is definitely booming

1 month ago

xiaolongbao

Clear the 17 wall slowly, can slowly push up and go for mid- long term

1 month ago

Travisbravis

Boss got new plan la, scrap the 70m plan & aim for new opportunities

1 month ago

Trianon

The new year is coming. People will go to the clinic to redeem aesthetic services 😁

1 month ago

Jimmy7890

Oops, still not 20cents yet, dropped further from my last comment. Good luck to Dr Chong paid fan 😄

1 month ago

gkungpat

Dr Cong bagi over dose sleeping pill..
Masih tidurrrrrr 😴😴😴

1 month ago

mf

Dow Jones

Dow Jones Industrial Average

42,740.42

-324.80

0.75%

Nasdaq

NASDAQ Composite

18,315.58

-187.10

1.01%

1 month ago

peaceKeeperGPT

dr chong haven't wake up

1 month ago

gkungpat

Target Price: RM0.200, RM0.220
Last closing price: RM0.180
Potential return: 11.1%, 22.2%
Support: RM0.175
Stop Loss: RM0.150


Huhuhuu
Still below IPO price..

4 weeks ago

mf

Dow member McDonald’s
closed more than 5% lower. The Centers for Disease Control and Prevention said late Tuesday that an E. coli outbreak tied to the fast-food giant’s Quarter Pounder burgers has resulted in 10 hospitalizations and one death.

4 weeks ago

GeraiRamlyburger

wah market red but drchong is green

3 weeks ago

gkungpat

New IPO coming similar to DCHCARE..
METRO HEALTHCARE BERHD..
Same IPO price with DCH..
Going down also like DCH..
Huhuhu

2 weeks ago

peaceKeeperGPT

aiyoyo DCHCARE supporter in shambles

2 weeks ago

Birdie

10 cents also expensive

2 weeks ago

gkungpat

Another EGM
Going to Bungkus Ikat Tepi also..

1 week ago

Travisbravis

Ada comeback chance?

1 week ago

gkungpat

Xde la tu..
Tunggu Dr Chong operate muka sendiri kasi orang x cam dia 🤭🤭🤭

1 week ago

JupiterMeow

DC Healthcare Holdings Berhad, has been actively expanding its operations by opening new branches across Malaysia. Their aggressive growth strategy has led to increased administrative and advertising expenses, contributing to recent financial losses. For instance, in the fourth quarter ended December 31, 2023, the company reported a net loss of RM1.07 million, despite achieving a revenue of RM17.57 million.

The share price has experienced a significant decline, closing at RM0.16 on November 8, 2024, marking a 69.23% drop over the past year. This downturn can be attributed to the financial losses and market concerns regarding the sustainability of its rapid expansion.

But I think the company's strategic initiatives, such as the establishment of new clinics in key locations like Johor Bahru and Ipoh, aim to tap into high-income markets and drive future revenue growth. Additionally, the implementation of an Employee Share Option Scheme (ESOS) is intended to align employee interests with company performance, potentially enhancing operational efficiency and profitability.

And I think, the share price may remain under pressure in the short term due to ongoing financial challenges and market scepticism. However, if the company's expansion efforts lead to increased market share and profitability, and if the ESOS successfully motivates employees to drive performance, there is potential for share price recovery in the medium to long term.

I think this will rebound sooner than later by 2nd Quarter 2025

1 week ago

JupiterMeow

Since its listing on Bursa, DCHCARE has encountered considerable financial challenges, reporting a net loss of RM18.49 million over the past twelve months and maintaining a negative profit margin of 32.82%. The stock has exhibited marked volatility, with weekly fluctuations averaging 10%, placing it among the top 25% of the most volatile stocks on the Malaysian market.

I believe the company’s strategy to expand its aesthetic services footprint—from 12 outlets in Q2 2023 to 17 in Q2 2024—alongside the launch of new product lines under the Ten Doctors brand and four additional outlets dedicated to slimming services, shows a strong commitment to growth. This increase, bringing the total to 21 outlets in Q2 2024 compared to the previous year’s 12, could create favourable prospects for financial recovery. However, the success of these initiatives will likely depend on broader market conditions and prevailing investor sentiment.

1 week ago

frick2fa

DR CHONG long gone

19 hours ago

Post a Comment